Compare Maravai LifeSciences Holdings Inc. Class A Common Stock (MRVI) vs TotalEnergies SE (TTE) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Maravai LifeSciences Holdings Inc. Class A Common Stock vs TotalEnergies SE — how do they compare? Maravai LifeSciences Holdings Inc. Class A Common Stock trades at $6.56 (market cap $972.90M), while TotalEnergies SE trades at $90.44 (market cap $196.57B). The key difference: TotalEnergies SE is far larger — about 202× Maravai LifeSciences Holdings Inc. Class A Common Stock's market cap, and TotalEnergies SE pays a 4.76% dividend while Maravai LifeSciences Holdings Inc. Class A Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Maravai LifeSciences Holdings Inc. Class A Common Stock for 0 Days and TotalEnergies SE for 91 Days on average.
| MRVI | TTE | |
|---|---|---|
Market Cap | $972.90M | $196.57B |
Volume | 4,325,710 | 2,606,285 |
Sector | Health | Energy |
52-Week High | $9.00 | $93.60 |
52-Week Low | $2.83 | $60.44 |
Typical Hold Time | 0 Days | 91 Days |
Enterprise Value | $1.08B | $227.56B |
Dividend Yield | — | 4.76% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Maravai LifeSciences (MRVI) trades at $6.53, down 7.51% in the last session amid mixed signals. The stock shows improving fundamentals with Q2 2026 revenue growth of 9% and three consecutive earnings beats, though it remains unprofitable with a -37.07% net margin. Technical analysis indicates neutral positioning with key support at $6 and resistance at $7. Recent news highlights patent expansions in China and institutional accumulation.
The outlook remains cautiously optimistic with analyst consensus pointing to 7% upside potential to the $7.00 price target. Key opportunities include margin expansion and RNA technology leadership, while risks center on persistent cash burn and competitive pressures in life sciences. The stock offers speculative growth potential for risk-tolerant investors.
TotalEnergies (TTE) trades at $89.64, up 1.44% today, with a bullish technical outlook and strong analyst support. The stock shows robust fundamentals with a P/E of 11.13 and net income margin of 9.08%, though revenue has declined from $263.3B in 2022 to $182.3B in 2025. Recent news highlights a $10B investment in Argentina and a $2.5B Q4 share buyback increase, reinforcing growth commitments. Earnings have beaten expectations in two of the last three quarters, with Q3 2026 results pending.
The outlook for TTE is positive, driven by strategic investments and shareholder returns, but faces risks from volatile energy prices and execution challenges. Wall Street consensus is bullish with a $95.33 price target, though investors should monitor oil price fluctuations and geopolitical factors that could impact profitability.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Maravai LifeSciences Holdings Inc. Class A Common Stock
Maravai LifeSciences Holdings Inc. is a life sciences company supporting drug therapy, diagnostic, and vaccine development through four operating brands: TriLink BioTechnologies (nucleic acid and mRNA synthesis), Cygnus Technologies (biologics safety testing), Glen Research (oligonucleotide synthesis materials), and Alphazyme (enzyme manufacturing). It serves biotech and biopharma customers from discovery through commercial manufacturing.
Read more on MRVI →About TotalEnergies SE
TotalEnergies is an integrated oil and gas company that explores for, produces, and refines oil around the world. In 2021, it produced 1.5 million barrels of liquids and 7.2 billion cubic feet of natural gas per day. At year-end 2020, reserves stood at 12.1 billion barrels of oil equivalent, 45% of which are liquids. During 2021, it had LNG sales of 42 Mt. The company owns interests in refineries with capacity of nearly 1.8 million barrels a day, primarily in Europe, distributes refined products in 65 countries, and manufactures commodity and specialty chemicals. It also holds a 19% interest in Russian oil company Novatek. At year-end, its gross installed renewable power generation capacity was 10.3 GW.
Read more on TTE →
